Cell-assay week is a poor time to discover that a certificate of analysis supports only part of the question. A purity percentage can look reassuring, but it does not tell a laboratory manager whether identity was confirmed on the batch, whether heavy metals or endotoxin were screened, or whether the vial in hand matches the document being cited. For research-use-only materials, the practical task is to ask for the tests behind the headline and build a documentation pack before the assay schedule begins. Research Sciences describes batch-level analytical verification and full-spectrum testing across purity, identity, heavy metals and endotoxin evaluation; those are starting points, but the researcher still needs to open the actual batch CoA. Products are not for human or veterinary use.
Why a purity headline needs a contaminant-screening companion
A headline figure such as “≥99% Verified Purity” is a marketing and catalogue signal, not a substitute for batch review. The Research Sciences homepage currently uses that wording alongside “CoAs Janoshik Analytical Reports”; treat both as published claims to reconfirm on the live site and, more importantly, against the CoA supplied with the specific batch. The FAQs say peptides are typically supplied at ≥99% purity by HPLC and that the exact purity is stated on the CoA. That is the correct place to look: one reconciled percentage copied from a category page cannot answer questions about the vial in front of you.
Purity by HPLC answers one part of the analytical picture. It can indicate the proportion of the main peak under the stated method, and the site describes HPLC as covering purity and identity. It does not, by itself, demonstrate that heavy metals and endotoxin have been evaluated for that batch. Contaminant screening is a separate conversation. Ask which tests were performed, whether they relate to the batch reference on the label, and where the results appear in the documentation. The site’s testing discussion refers to heavy-metal evaluation by ICP-MS and endotoxin testing; researchers should use those site-published descriptions as prompts for verification rather than assuming that every vial carries an identical test set.
This distinction matters most before a scheduled cell-assay week, when changes to materials, handling or documentation can disrupt a tightly booked culture schedule. A materials manager should not accept “high purity” as a complete release note. The useful question is: what was screened, on which sample, and does the answer match this delivery? If a supplier cannot point to a batch-specific document, the headline remains a headline. Products remain for controlled laboratory and analytical research only and are not for human or veterinary use, consumption, administration or clinical application.
What to request from the documentation pack before the assay week
The documentation request should be specific enough to survive a busy week. Begin with the vial label and its reference format, which the site describes as a SKU code plus expiry date, such as BPC10-03/27. Quote that reference when contacting the shop about documentation. The current research catalogue can be reviewed through Buy peptides, but the catalogue listing is only a signpost; the batch CoA and the individual product page are where the material in hand should be checked. Do not rely on a category description to settle a batch question.
Match the vial, the reference and the CoA
Ask for the CoA that corresponds to the batch reference on the vial and confirm that the document covers purity and identity as stated by the supplier. The FAQ says every product includes a CoA for HPLC purity and identity, with final verification and quality checks in the UK before release. Verify that statement on the actual document rather than assuming it from the listing. If the CoA has a report number or sample reference, record it in the materials file alongside the vial reference and the date received. This creates an audit trail for the assay week without inventing specifications that are not printed on the certificate.
Ask which contaminant tests were run on the batch
For contaminant screening, ask directly whether heavy metals and endotoxin evaluation were performed on the batch and where those results are reported. Do not invent pass or fail limits on the supplier’s behalf; read the limits and method statements that the CoA or associated report actually contains. If the site’s wording mentions a testing framework, treat it as a prompt to check the batch document, not as proof that every catalogue item carries the same panel. If Janoshik is named in the homepage wording, the researcher should open and check the CoA that accompanies the specific batch rather than treating the laboratory name alone as a result.
Treat ITRs and cap colours with the right level of caution
The FAQs note that restocked products may carry the same Internal Test Reference as earlier stock. An ITR links to associated sample testing reports; it does not confirm that separate deliveries come from the same production lot or have had separate independent testing. Vial cap colours and other packaging may vary, and cap colour is not an indicator of identity, analytical quality or manufacturing origin. For a cell-assay week, the safer approach is to record the ITR, the batch label and the CoA together, then decide whether the documentation is adequate for the experimental design. Products are research-use-only and are not for human or veterinary use.
A practical pre-assay workflow for materials managers
A realistic scenario is a laboratory preparing a scheduled cell-assay week with several lyophilised research peptides, including a restocked item and a vial from an earlier delivery. The materials manager should not assume that identical product names mean identical documentation. First, reconcile every vial against its label reference and CoA. Second, separate the questions of purity, identity, heavy metals and endotoxin, noting which answers are batch-specific. Third, check storage history: the site advises lyophilised peptides at −20°C or below, sealed with desiccant and protected from moisture, heat and light, with avoidance of repeated freeze–thaw cycles. Fourth, confirm that handling instructions fit an in-vitro workflow: allow vials to reach room temperature before opening, work in a clean environment, and remove only the amount required for the experiment.
Where reconstitution is part of the laboratory method, keep the discussion inside the in-vitro context. The site says reconstitution solutions are supplied separately and that, after reconstitution, peptides should be stored at 2–8°C for short-term laboratory use. The free reconstitution calculator is described for laboratory research use only and must not be used for human or veterinary dosing. Record diluent volume and concentration for the assay, not for administration. The FAQ also states that peptides contain trace amounts of mannitol as an excipient; that does not remove the need to ask about contaminant screening or to read the batch CoA.
Fulfilment and storage terms should be reconfirmed at the point of order. Published terms state next-working-day dispatch and Royal Mail Tracked 24, with delivery estimates that may vary; the homepage “24hr UK Delivery” line should not be read as a guarantee. Temperature-aware storage and tracked UK dispatch do not replace analytical documentation. Before the first plate is scheduled, the materials manager should have a signed-off pack containing the vial reference, the batch CoA, the contaminant-testing questions and answers, storage records and the in-vitro handling note. Materials remain for research use only and are not for human or veterinary use.
